Astrazeneca AZN
NYSE AZN
$171.47 -1.13 (-0.65%)
At close: Oct 23, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Astrazeneca (AZN) reported Return on Capital Employed [ROCE] of 9.54% for Q2 2026, up 1.61 percentage points from 7.93% a year earlier but down 0.23 percentage points from the prior quarter.

Analysis

Astrazeneca (AZN) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Astrazeneca posted Return on Capital Employed [ROCE] of 9.84%, up 2.17 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased for four consecutive years, with a five-year change of +3.72 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at 7.67% in FY2024 (+1.33 pp), 6.33% in FY2023 (+3.38 pp), 2.95% in FY2022 (+1.98 pp) and 0.97% in FY2021 (-5.15 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -0.46% in Q2 2022 and a high of 9.76% in Q1 2026.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last 15 quarters, with an average year-over-year change of +1.39 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2023 (a gain of 6.43 percentage points); the low point was Q2 2022 (a drop of 6.66 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 9.76% (Q1 2026), 9.49% (Q4 2025) and 8.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 Vertex Pharmaceuticals 132.74 Bn 104.74 Bn 2.84 Bn 20.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.76%
Mar 31, 2026 9.76%
Dec 31, 2025 16.43%
Sep 30, 2025 8.68%
Jun 30, 2025 14.94%
Mar 31, 2025 7.87%
Dec 31, 2024 13.06%
Sep 30, 2024 7.05%
Jun 30, 2024 12.11%
Mar 31, 2024 6.71%
Dec 31, 2023 12.04%
Sep 30, 2023 6.45%
Jun 30, 2023 10.46%
Mar 31, 2023 4.47%
Dec 31, 2022 5.44%
Sep 30, 2022 1.97%
Jun 30, 2022 -0.72%
Mar 31, 2022 0.03%
Dec 31, 2021 1.26%
Sep 30, 2021 2.49%
API Access

Astrazeneca Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AZN&period=max&api_key=YOUR_API_KEY